Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 5 | Rare Historical Photos

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

StockNews.com

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Independent UK

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Gary Vee, Kevin Durant, Alex Rodriguez Backed Tracer Land New Investors

Data intelligence platform, Tracer, announced a new president to lead the company

Zenger

Gen Z needs brand-new skills to climb to the C-suite, says healthcare CEO

Knowing how to use and implement generative A.I. will be a “minimum expectation” for future CEOs, Sanofi CEO Paul Hudson said.

Fortune

U.S. firm StemCures to set up manufacturing lab in Telangana

StemCures, a medical clinic in Ohio focused on stem cell therapy, will be establishing a manufacturing lab in Telangana with around $54 million investment and employment potential for around 150 people.

The Hindu

Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’

'Innovation is powered by more than just money,' writes Sanofi CEO Paul Hudson.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

Evening Standard

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

The Week

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

Wales Online

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Conversation

Newsom announces $50 million contract to make California’s own brand of insulin

LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.

Los Angeles Times

Michael Hiltzik: Eli Lilly is slashing insulin prices, but hold your applause

Eli Lilly & Co. played the altruism card like a champ on Mar. 1, when it announced steep price cuts on its insulin products of as much as 70%.

Los Angeles Times

The biggest U.S. pharmaceutical companies are lowering insulin costs to save themselves money

So much for altruism.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Why does insulin cost so much? Big Pharma isn’t the only player driving prices

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.

Evening Standard

What is the UK’s Covid-19 spring booster programme and who is eligible for a vaccine?

London is still lagging behind parts of the country in terms of the vaccine uptake

Wales Online

Woman, 42, told she would not live past childhood surpassed prognosis by decades

Katie Eliot said she has experienced ‘amazing things’ in her life, despite bleak medical predictions in her youth

Fortune

Four keys to building your company's synthetic biology strategy

Big incumbent companies can't afford to fall behind in a new tech-and-science arms race.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Woman’s rare condition left her with tumours all over her body

Katie Eliot, 42, was diagnosed with tuberous sclerosis at 18 years old

Fortune

Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It's a market that will be worth up to $10 billion in a decade

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

Wales Online

'I've had purple urine since I was in nappies, but only found out why aged 53'

Tony has Alkaptonuria (AKU), also known as black bone or black urine disease

Salon

A technicality could withhold RSV shots

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

The Conversation

Yes, masks reduce the risk of spreading COVID, despite a review saying they don't

The question of whether and to what extent face masks work to prevent respiratory infections such as COVID and influenza has split the scientific community for decades.

Daily Mirror

Chloe Madeley went back to work just 8 weeks after giving birth as she 'needs the money'

Chloe Madeley - the daughter of TV stars Richard Madeley and Judy Finnigan - cut her maternity leave short because she didn't want to take her husband James Haskell's money

Fortune

People are much less likely to trust the medical system if they are from an ethnic minority, have disabilities, or identify as LGBTQ+, according to a first-of-its-kind study by Sanofi

In the U.S., 77% of people with disabilities, 69% of people from ethnic minorities, and 70% of LGBTQ+ people are less likely to trust the medical system.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.